Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimodulin in Severe Community-acquired Pneumonia (sCAP)
NCT05722938Phase 3Recruiting
- Sponsor
- Biotest AG
- Start
- Sep 2023
- Primary completion
- Jul 2028
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 18
01
Overview
A Phase 3 trial of Pentaglobin in community acquired pneumonia (CAP), sponsored by Biotest AG. Started Sep 2023; status: recruiting.
02
Drugs
Pentaglobin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT05722938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05722938.